nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—DRD5—bipolar disorder	0.194	0.252	CbGaD
Aripiprazole—DRD4—bipolar disorder	0.099	0.129	CbGaD
Aripiprazole—DRD3—bipolar disorder	0.0854	0.111	CbGaD
Aripiprazole—DRD1—bipolar disorder	0.0838	0.109	CbGaD
Aripiprazole—HTR2C—bipolar disorder	0.0717	0.0934	CbGaD
Aripiprazole—HTR1A—bipolar disorder	0.0696	0.0907	CbGaD
Aripiprazole—SLC6A4—bipolar disorder	0.0594	0.0774	CbGaD
Aripiprazole—DRD2—bipolar disorder	0.0591	0.077	CbGaD
Aripiprazole—HTR2A—bipolar disorder	0.0457	0.0595	CbGaD
Aripiprazole—DRD3—telencephalic ventricle—bipolar disorder	0.0043	0.064	CbGeAlD
Aripiprazole—HTR7—locus ceruleus—bipolar disorder	0.00405	0.0604	CbGeAlD
Aripiprazole—DRD1—telencephalic ventricle—bipolar disorder	0.00308	0.0459	CbGeAlD
Aripiprazole—HTR2A—locus ceruleus—bipolar disorder	0.00253	0.0377	CbGeAlD
Aripiprazole—HTR1B—telencephalic ventricle—bipolar disorder	0.00249	0.0372	CbGeAlD
Aripiprazole—HTR1D—telencephalic ventricle—bipolar disorder	0.00241	0.036	CbGeAlD
Aripiprazole—HTR2C—telencephalic ventricle—bipolar disorder	0.00239	0.0356	CbGeAlD
Aripiprazole—HTR7—autonomic nervous system—bipolar disorder	0.00215	0.0321	CbGeAlD
Aripiprazole—HTR1A—telencephalic ventricle—bipolar disorder	0.00201	0.03	CbGeAlD
Aripiprazole—HTR7—telencephalic ventricle—bipolar disorder	0.00192	0.0287	CbGeAlD
Aripiprazole—DRD2—telencephalic ventricle—bipolar disorder	0.00182	0.0271	CbGeAlD
Aripiprazole—HTR2A—autonomic nervous system—bipolar disorder	0.00134	0.02	CbGeAlD
Aripiprazole—HTR2A—telencephalic ventricle—bipolar disorder	0.0012	0.0179	CbGeAlD
Aripiprazole—HTR2A—urine—bipolar disorder	0.00109	0.0163	CbGeAlD
Aripiprazole—SLC6A4—blood plasma—bipolar disorder	0.00108	0.0161	CbGeAlD
Aripiprazole—CYP3A4—urine—bipolar disorder	0.00101	0.0151	CbGeAlD
Aripiprazole—CYP2D6—urine—bipolar disorder	0.000997	0.0149	CbGeAlD
Aripiprazole—HTR1A—blood plasma—bipolar disorder	0.000959	0.0143	CbGeAlD
Aripiprazole—HTR7—blood plasma—bipolar disorder	0.000916	0.0137	CbGeAlD
Aripiprazole—H1F0—adrenal cortex—bipolar disorder	0.000754	0.0112	CbGeAlD
Aripiprazole—HTR1E—nervous system—bipolar disorder	0.000747	0.0111	CbGeAlD
Aripiprazole—CYP3A5—blood plasma—bipolar disorder	0.000705	0.0105	CbGeAlD
Aripiprazole—ADRA2A—blood plasma—bipolar disorder	0.000672	0.01	CbGeAlD
Aripiprazole—DRD4—brain—bipolar disorder	0.000662	0.00987	CbGeAlD
Aripiprazole—CHRM4—nervous system—bipolar disorder	0.000655	0.00976	CbGeAlD
Aripiprazole—Ziprasidone—DRD5—bipolar disorder	0.000613	0.0947	CrCbGaD
Aripiprazole—DRD3—nervous system—bipolar disorder	0.000609	0.00908	CbGeAlD
Aripiprazole—HTR6—nervous system—bipolar disorder	0.000586	0.00874	CbGeAlD
Aripiprazole—Vilazodone—HTR1A—bipolar disorder	0.000582	0.0899	CrCbGaD
Aripiprazole—HTR2A—blood plasma—bipolar disorder	0.000571	0.00852	CbGeAlD
Aripiprazole—HTR1E—brain—bipolar disorder	0.000571	0.00851	CbGeAlD
Aripiprazole—DRD5—nervous system—bipolar disorder	0.000571	0.00851	CbGeAlD
Aripiprazole—HTR2B—adrenal cortex—bipolar disorder	0.000543	0.0081	CbGeAlD
Aripiprazole—CYP3A4—blood plasma—bipolar disorder	0.000529	0.00788	CbGeAlD
Aripiprazole—H1F0—thyroid gland—bipolar disorder	0.000525	0.00783	CbGeAlD
Aripiprazole—CYP2D6—blood plasma—bipolar disorder	0.000521	0.00776	CbGeAlD
Aripiprazole—CHRM5—nervous system—bipolar disorder	0.000512	0.00763	CbGeAlD
Aripiprazole—CHRM4—brain—bipolar disorder	0.000501	0.00746	CbGeAlD
Aripiprazole—Vilazodone—SLC6A4—bipolar disorder	0.000497	0.0767	CrCbGaD
Aripiprazole—Vilazodone—DRD2—bipolar disorder	0.000494	0.0763	CrCbGaD
Aripiprazole—ADRA1B—nervous system—bipolar disorder	0.000468	0.00697	CbGeAlD
Aripiprazole—DRD3—brain—bipolar disorder	0.000465	0.00694	CbGeAlD
Aripiprazole—HTR6—brain—bipolar disorder	0.000448	0.00668	CbGeAlD
Aripiprazole—H1F0—nervous system—bipolar disorder	0.000442	0.00658	CbGeAlD
Aripiprazole—DRD5—brain—bipolar disorder	0.000436	0.0065	CbGeAlD
Aripiprazole—DRD1—nervous system—bipolar disorder	0.000436	0.0065	CbGeAlD
Aripiprazole—ADRA2C—adrenal cortex—bipolar disorder	0.000427	0.00637	CbGeAlD
Aripiprazole—HTR3A—nervous system—bipolar disorder	0.000421	0.00628	CbGeAlD
Aripiprazole—H1F0—cerebellum—bipolar disorder	0.000416	0.00619	CbGeAlD
Aripiprazole—CHRM5—brain—bipolar disorder	0.000391	0.00583	CbGeAlD
Aripiprazole—HTR2B—thyroid gland—bipolar disorder	0.000378	0.00564	CbGeAlD
Aripiprazole—ABCB1—blood plasma—bipolar disorder	0.000374	0.00558	CbGeAlD
Aripiprazole—ADRA1B—brain—bipolar disorder	0.000358	0.00533	CbGeAlD
Aripiprazole—HTR1B—nervous system—bipolar disorder	0.000353	0.00527	CbGeAlD
Aripiprazole—CHRM2—nervous system—bipolar disorder	0.000351	0.00524	CbGeAlD
Aripiprazole—HTR1D—nervous system—bipolar disorder	0.000342	0.0051	CbGeAlD
Aripiprazole—CHRM3—thyroid gland—bipolar disorder	0.00034	0.00507	CbGeAlD
Aripiprazole—HTR2C—nervous system—bipolar disorder	0.000339	0.00505	CbGeAlD
Aripiprazole—H1F0—brain—bipolar disorder	0.000338	0.00503	CbGeAlD
Aripiprazole—DRD1—brain—bipolar disorder	0.000333	0.00497	CbGeAlD
Aripiprazole—ADRB1—nervous system—bipolar disorder	0.000332	0.00496	CbGeAlD
Aripiprazole—HTR3A—brain—bipolar disorder	0.000322	0.0048	CbGeAlD
Aripiprazole—SLC6A4—nervous system—bipolar disorder	0.000321	0.00479	CbGeAlD
Aripiprazole—CHRM1—nervous system—bipolar disorder	0.00032	0.00477	CbGeAlD
Aripiprazole—HTR2B—nervous system—bipolar disorder	0.000318	0.00474	CbGeAlD
Aripiprazole—Ziprasidone—DRD4—bipolar disorder	0.000314	0.0484	CrCbGaD
Aripiprazole—CHRM3—nervous system—bipolar disorder	0.000286	0.00427	CbGeAlD
Aripiprazole—HTR1A—nervous system—bipolar disorder	0.000285	0.00425	CbGeAlD
Aripiprazole—HTR7—nervous system—bipolar disorder	0.000272	0.00406	CbGeAlD
Aripiprazole—Ziprasidone—DRD3—bipolar disorder	0.00027	0.0418	CrCbGaD
Aripiprazole—HTR1B—brain—bipolar disorder	0.00027	0.00403	CbGeAlD
Aripiprazole—CHRM2—brain—bipolar disorder	0.000269	0.004	CbGeAlD
Aripiprazole—HTR1A—cerebellum—bipolar disorder	0.000268	0.004	CbGeAlD
Aripiprazole—Ziprasidone—DRD1—bipolar disorder	0.000265	0.041	CrCbGaD
Aripiprazole—ADRA1A—nervous system—bipolar disorder	0.000263	0.00392	CbGeAlD
Aripiprazole—HTR1D—brain—bipolar disorder	0.000261	0.0039	CbGeAlD
Aripiprazole—HTR2C—brain—bipolar disorder	0.000259	0.00386	CbGeAlD
Aripiprazole—DRD2—nervous system—bipolar disorder	0.000258	0.00384	CbGeAlD
Aripiprazole—HTR7—cerebellum—bipolar disorder	0.000256	0.00382	CbGeAlD
Aripiprazole—ADRB1—brain—bipolar disorder	0.000254	0.00379	CbGeAlD
Aripiprazole—KCNH2—nervous system—bipolar disorder	0.000254	0.00378	CbGeAlD
Aripiprazole—ADRA2C—nervous system—bipolar disorder	0.00025	0.00373	CbGeAlD
Aripiprazole—ADRA1A—cerebellum—bipolar disorder	0.000247	0.00369	CbGeAlD
Aripiprazole—SLC6A4—brain—bipolar disorder	0.000245	0.00366	CbGeAlD
Aripiprazole—CHRM1—brain—bipolar disorder	0.000245	0.00364	CbGeAlD
Aripiprazole—HTR2B—brain—bipolar disorder	0.000243	0.00363	CbGeAlD
Aripiprazole—DRD2—cerebellum—bipolar disorder	0.000242	0.00361	CbGeAlD
Aripiprazole—KCNH2—cerebellum—bipolar disorder	0.000239	0.00356	CbGeAlD
Aripiprazole—ADRA2A—thyroid gland—bipolar disorder	0.000238	0.00354	CbGeAlD
Aripiprazole—ADRA2C—cerebellum—bipolar disorder	0.000236	0.00351	CbGeAlD
Aripiprazole—Ziprasidone—HTR2C—bipolar disorder	0.000227	0.0351	CrCbGaD
Aripiprazole—Ziprasidone—HTR1A—bipolar disorder	0.00022	0.034	CrCbGaD
Aripiprazole—CHRM3—brain—bipolar disorder	0.000219	0.00326	CbGeAlD
Aripiprazole—HTR1A—brain—bipolar disorder	0.000218	0.00325	CbGeAlD
Aripiprazole—Nefazodone—SLC6A3—bipolar disorder	0.000212	0.0327	CrCbGaD
Aripiprazole—HTR7—brain—bipolar disorder	0.000208	0.0031	CbGeAlD
Aripiprazole—HRH1—nervous system—bipolar disorder	0.000203	0.00303	CbGeAlD
Aripiprazole—ADRA1A—brain—bipolar disorder	0.000201	0.00299	CbGeAlD
Aripiprazole—ADRA2A—nervous system—bipolar disorder	0.0002	0.00298	CbGeAlD
Aripiprazole—DRD2—brain—bipolar disorder	0.000197	0.00294	CbGeAlD
Aripiprazole—KCNH2—brain—bipolar disorder	0.000194	0.00289	CbGeAlD
Aripiprazole—ADRA2C—brain—bipolar disorder	0.000191	0.00285	CbGeAlD
Aripiprazole—Nefazodone—HTR2C—bipolar disorder	0.000191	0.0295	CrCbGaD
Aripiprazole—ABCB1—adrenal cortex—bipolar disorder	0.00019	0.00283	CbGeAlD
Aripiprazole—Prochlorperazine—DRD3—bipolar disorder	0.000188	0.0291	CrCbGaD
Aripiprazole—Ziprasidone—SLC6A4—bipolar disorder	0.000188	0.0291	CrCbGaD
Aripiprazole—ADRA2A—cerebellum—bipolar disorder	0.000188	0.0028	CbGeAlD
Aripiprazole—Ziprasidone—DRD2—bipolar disorder	0.000187	0.0289	CrCbGaD
Aripiprazole—Nefazodone—HTR1A—bipolar disorder	0.000185	0.0286	CrCbGaD
Aripiprazole—Trazodone—HTR2C—bipolar disorder	0.000177	0.0273	CrCbGaD
Aripiprazole—Trazodone—HTR1A—bipolar disorder	0.000171	0.0265	CrCbGaD
Aripiprazole—HTR2A—nervous system—bipolar disorder	0.00017	0.00253	CbGeAlD
Aripiprazole—HTR2A—cerebellum—bipolar disorder	0.00016	0.00238	CbGeAlD
Aripiprazole—Nefazodone—SLC6A4—bipolar disorder	0.000158	0.0244	CrCbGaD
Aripiprazole—Prochlorperazine—HTR2C—bipolar disorder	0.000158	0.0244	CrCbGaD
Aripiprazole—CYP3A4—nervous system—bipolar disorder	0.000157	0.00234	CbGeAlD
Aripiprazole—HRH1—brain—bipolar disorder	0.000156	0.00232	CbGeAlD
Aripiprazole—CYP2D6—nervous system—bipolar disorder	0.000155	0.00231	CbGeAlD
Aripiprazole—ADRA2A—brain—bipolar disorder	0.000153	0.00228	CbGeAlD
Aripiprazole—Trazodone—SLC6A4—bipolar disorder	0.000146	0.0226	CrCbGaD
Aripiprazole—CYP2D6—cerebellum—bipolar disorder	0.000146	0.00217	CbGeAlD
Aripiprazole—Ziprasidone—HTR2A—bipolar disorder	0.000145	0.0223	CrCbGaD
Aripiprazole—ABCB1—thyroid gland—bipolar disorder	0.000132	0.00197	CbGeAlD
Aripiprazole—Perphenazine—DRD1—bipolar disorder	0.000132	0.0204	CrCbGaD
Aripiprazole—Prochlorperazine—DRD2—bipolar disorder	0.00013	0.0201	CrCbGaD
Aripiprazole—HTR2A—brain—bipolar disorder	0.00013	0.00194	CbGeAlD
Aripiprazole—Nefazodone—HTR2A—bipolar disorder	0.000122	0.0188	CrCbGaD
Aripiprazole—CYP2D6—brain—bipolar disorder	0.000118	0.00176	CbGeAlD
Aripiprazole—Perphenazine—HTR2C—bipolar disorder	0.000113	0.0175	CrCbGaD
Aripiprazole—Trazodone—HTR2A—bipolar disorder	0.000112	0.0174	CrCbGaD
Aripiprazole—ABCB1—nervous system—bipolar disorder	0.000111	0.00166	CbGeAlD
Aripiprazole—Perphenazine—HTR1A—bipolar disorder	0.00011	0.017	CrCbGaD
Aripiprazole—ABCB1—cerebellum—bipolar disorder	0.000105	0.00156	CbGeAlD
Aripiprazole—Perphenazine—DRD2—bipolar disorder	9.32e-05	0.0144	CrCbGaD
Aripiprazole—ABCB1—brain—bipolar disorder	8.51e-05	0.00127	CbGeAlD
Aripiprazole—Perphenazine—HTR2A—bipolar disorder	7.2e-05	0.0111	CrCbGaD
Aripiprazole—HRH1—Signaling Pathways—DRD4—bipolar disorder	4.29e-06	2.7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—DRD4—bipolar disorder	4.28e-06	2.69e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—S100B—bipolar disorder	4.27e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—DRD4—bipolar disorder	4.26e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—HTR2A—bipolar disorder	4.26e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—POMC—bipolar disorder	4.25e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—POMC—bipolar disorder	4.24e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	4.24e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—DPYD—bipolar disorder	4.23e-06	2.66e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—S100B—bipolar disorder	4.23e-06	2.66e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—DRD4—bipolar disorder	4.22e-06	2.65e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	4.21e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	4.2e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—HTR2A—bipolar disorder	4.19e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—NRG1—bipolar disorder	4.19e-06	2.63e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	4.18e-06	2.63e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	4.18e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	4.18e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—POMC—bipolar disorder	4.17e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CLOCK—bipolar disorder	4.16e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	4.16e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	4.16e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	4.15e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	4.14e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	4.14e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—NRG1—bipolar disorder	4.13e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—ADCY2—bipolar disorder	4.11e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—COMT—bipolar disorder	4.11e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	4.1e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	4.1e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	4.09e-06	2.57e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—S100B—bipolar disorder	4.08e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—MAOA—bipolar disorder	4.08e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NTRK1—bipolar disorder	4.06e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—S100B—bipolar disorder	4.06e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—TPH2—bipolar disorder	4.06e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—TSHB—bipolar disorder	4.06e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CACNB2—bipolar disorder	4.06e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	4.05e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	4.05e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—ADCY2—bipolar disorder	4.04e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ADCY2—bipolar disorder	4.04e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	4.03e-06	2.53e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	4.03e-06	2.53e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	4.03e-06	2.53e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	4.02e-06	2.53e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NR1D1—bipolar disorder	4.02e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	4.01e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	4.01e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	4.01e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—DRD2—bipolar disorder	4.01e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—HTR2A—bipolar disorder	4e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	4e-06	2.51e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	4e-06	2.51e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—DRD2—bipolar disorder	4e-06	2.51e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—DPYD—bipolar disorder	3.99e-06	2.51e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—DRD2—bipolar disorder	3.98e-06	2.5e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	3.97e-06	2.5e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—DRD2—bipolar disorder	3.97e-06	2.49e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	3.96e-06	2.49e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	3.96e-06	2.49e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	3.96e-06	2.49e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	3.95e-06	2.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—S100B—bipolar disorder	3.95e-06	2.48e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CACNA1C—bipolar disorder	3.94e-06	2.47e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—DRD2—bipolar disorder	3.93e-06	2.47e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	3.92e-06	2.46e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	3.91e-06	2.46e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—S100B—bipolar disorder	3.89e-06	2.44e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—MTHFR—bipolar disorder	3.86e-06	2.43e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—POMC—bipolar disorder	3.85e-06	2.42e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NCAN—bipolar disorder	3.84e-06	2.41e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3C2A—bipolar disorder	3.84e-06	2.41e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	3.8e-06	2.39e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—POMC—bipolar disorder	3.79e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—POMC—bipolar disorder	3.78e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—HTR2A—bipolar disorder	3.78e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—POMC—bipolar disorder	3.77e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—COMT—bipolar disorder	3.77e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—NRG1—bipolar disorder	3.77e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—SLC5A3—bipolar disorder	3.76e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—POMC—bipolar disorder	3.76e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—MTHFR—bipolar disorder	3.75e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—MAOA—bipolar disorder	3.74e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NRG1—bipolar disorder	3.73e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—HTR2A—bipolar disorder	3.73e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—POMC—bipolar disorder	3.72e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	3.71e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CACNA1C—bipolar disorder	3.71e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NTRK1—bipolar disorder	3.69e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	3.68e-06	2.31e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	3.67e-06	2.31e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	3.64e-06	2.29e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	3.63e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NTRK1—bipolar disorder	3.62e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	3.61e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	3.61e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NRG1—bipolar disorder	3.6e-06	2.26e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	3.6e-06	2.26e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NRG1—bipolar disorder	3.58e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—S100B—bipolar disorder	3.58e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	3.56e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	3.55e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—GSK3B—bipolar disorder	3.53e-06	2.22e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—GSK3B—bipolar disorder	3.53e-06	2.22e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—S100B—bipolar disorder	3.53e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—S100B—bipolar disorder	3.52e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—S100B—bipolar disorder	3.51e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—GSK3B—bipolar disorder	3.5e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—POMC—bipolar disorder	3.5e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—POMC—bipolar disorder	3.5e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—S100B—bipolar disorder	3.5e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NRG1—bipolar disorder	3.48e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—INS—bipolar disorder	3.48e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—INS—bipolar disorder	3.48e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—POMC—bipolar disorder	3.48e-06	2.18e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—S100B—bipolar disorder	3.46e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—INS—bipolar disorder	3.46e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—COMT—bipolar disorder	3.46e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—S100B—bipolar disorder	3.45e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	3.45e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—SNAP25—bipolar disorder	3.44e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—GSK3B—bipolar disorder	3.43e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—MAOA—bipolar disorder	3.43e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	3.43e-06	2.15e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—POMC—bipolar disorder	3.4e-06	2.14e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	3.39e-06	2.13e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—INS—bipolar disorder	3.39e-06	2.13e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—GSK3B—bipolar disorder	3.38e-06	2.12e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—HTR2A—bipolar disorder	3.36e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—POMC—bipolar disorder	3.35e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	3.33e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—INS—bipolar disorder	3.33e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—MTHFR—bipolar disorder	3.32e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—POMC—bipolar disorder	3.3e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	3.3e-06	2.07e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—INS—bipolar disorder	3.29e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	3.25e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—SNAP25—bipolar disorder	3.24e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	3.23e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—GSK3B—bipolar disorder	3.22e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—S100B—bipolar disorder	3.21e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—POMC—bipolar disorder	3.2e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	3.19e-06	2e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—INS—bipolar disorder	3.18e-06	2e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—POMC—bipolar disorder	3.16e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NRG1—bipolar disorder	3.16e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—INS—bipolar disorder	3.15e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—HTR2A—bipolar disorder	3.14e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NRG1—bipolar disorder	3.11e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NRG1—bipolar disorder	3.1e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NRG1—bipolar disorder	3.09e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	3.09e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—POMC—bipolar disorder	3.09e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NRG1—bipolar disorder	3.08e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—INS—bipolar disorder	3.07e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NRG1—bipolar disorder	3.05e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—MTHFR—bipolar disorder	3.05e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	3.05e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ADCY2—bipolar disorder	3.04e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—GSK3B—bipolar disorder	3.04e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—POMC—bipolar disorder	3.02e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—POMC—bipolar disorder	3e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—GSK3B—bipolar disorder	3e-06	1.88e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—INS—bipolar disorder	3e-06	1.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—INS—bipolar disorder	2.98e-06	1.87e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—POMC—bipolar disorder	2.98e-06	1.87e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—INS—bipolar disorder	2.96e-06	1.86e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ADCY2—bipolar disorder	2.87e-06	1.8e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—HTR2A—bipolar disorder	2.85e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	2.83e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—HTR2A—bipolar disorder	2.8e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—MTHFR—bipolar disorder	2.79e-06	1.75e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	2.79e-06	1.75e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	2.78e-06	1.75e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	2.75e-06	1.73e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	2.75e-06	1.73e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	2.73e-06	1.72e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CLOCK—bipolar disorder	2.72e-06	1.71e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—POMC—bipolar disorder	2.71e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—GSK3B—bipolar disorder	2.71e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—INS—bipolar disorder	2.7e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—POMC—bipolar disorder	2.69e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—INS—bipolar disorder	2.67e-06	1.68e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—POMC—bipolar disorder	2.66e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CACNB2—bipolar disorder	2.65e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—TSHB—bipolar disorder	2.65e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—TPH2—bipolar disorder	2.65e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—INS—bipolar disorder	2.64e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	2.61e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—DPYD—bipolar disorder	2.61e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—COMT—bipolar disorder	2.61e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	2.6e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—POMC—bipolar disorder	2.59e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—MAOA—bipolar disorder	2.59e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—POMC—bipolar disorder	2.58e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—INS—bipolar disorder	2.58e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—INS—bipolar disorder	2.57e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	2.55e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—GSK3B—bipolar disorder	2.53e-06	1.59e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—POMC—bipolar disorder	2.51e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—INS—bipolar disorder	2.5e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	2.49e-06	1.56e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—POMC—bipolar disorder	2.47e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—COMT—bipolar disorder	2.46e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—INS—bipolar disorder	2.46e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—MAOA—bipolar disorder	2.44e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—POMC—bipolar disorder	2.44e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CACNA1C—bipolar disorder	2.43e-06	1.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—INS—bipolar disorder	2.42e-06	1.52e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	2.36e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—GSK3B—bipolar disorder	2.3e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—POMC—bipolar disorder	2.28e-06	1.43e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—INS—bipolar disorder	2.26e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	2.26e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—GSK3B—bipolar disorder	2.25e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	2.25e-06	1.41e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—POMC—bipolar disorder	2.24e-06	1.41e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	2.24e-06	1.41e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—POMC—bipolar disorder	2.24e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—POMC—bipolar disorder	2.23e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—POMC—bipolar disorder	2.23e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—INS—bipolar disorder	2.23e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—INS—bipolar disorder	2.22e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—INS—bipolar disorder	2.22e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—POMC—bipolar disorder	2.22e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	2.22e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—INS—bipolar disorder	2.22e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	2.21e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—INS—bipolar disorder	2.21e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—POMC—bipolar disorder	2.2e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—POMC—bipolar disorder	2.19e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—INS—bipolar disorder	2.19e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—INS—bipolar disorder	2.18e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—SNAP25—bipolar disorder	2.12e-06	1.33e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—MTHFR—bipolar disorder	2.11e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	2.05e-06	1.29e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—POMC—bipolar disorder	2.04e-06	1.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—INS—bipolar disorder	2.03e-06	1.27e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.99e-06	1.25e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ADCY2—bipolar disorder	1.88e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—POMC—bipolar disorder	1.69e-06	1.06e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—INS—bipolar disorder	1.68e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—COMT—bipolar disorder	1.61e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MAOA—bipolar disorder	1.6e-06	1e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—POMC—bipolar disorder	1.59e-06	9.98e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—INS—bipolar disorder	1.58e-06	9.92e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MTHFR—bipolar disorder	1.3e-06	8.16e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—POMC—bipolar disorder	1.04e-06	6.52e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—INS—bipolar disorder	1.03e-06	6.49e-06	CbGpPWpGaD
